相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Potential cerebrovascular accident signal for risankizumab: A disproportionality analysis of the FDA Adverse Event Reporting System (FAERS)
Richard H. Woods
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)
Interleukin-17 Links Inflammatory Cross-Talks Between Comorbid Psoriasis and Atherosclerosis
Yan Wang et al.
FRONTIERS IN IMMUNOLOGY (2022)
Apremilast exerts protective effects on stroke outcomes and blood-brain barrier (BBB) dysfunction through regulating Rho-associated protein kinase 2 expression
Mingyuan Wang et al.
BRAIN AND BEHAVIOR (2022)
French administrative health care database (SNDS): The value of its enrichment
Lucie-Marie Scailteux et al.
THERAPIE (2019)
The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology
Julien Bezin et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
Psoriasis and the Risk of Major Cardiovascular Events: Cohort Study Using the Clinical Practice Research Datalink
Rosa Parisi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Attributable Risk Estimate of Severe Psoriasis on Major Cardiovascular Events
Nehal N. Mehta et al.
AMERICAN JOURNAL OF MEDICINE (2011)